Retrospective Study
Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 26, 2022; 10(21): 7302-7313
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7302
Table 1 Demographical characteristics and clinical data of the patients
Variables DICH group (n = 26) Non-DICH group (n = 133) P value Age (yr) 51.35 ± 12.08 53.89 ± 15.17 0.422 Male gender, n (%) 17 (65.38) 66 (49.62) 0.141 Primary intracranial lesion, n (%) 0.679 Traumatic brain injury 6 (23.07) 43 (17.29) Intracranial hemorrhage 5 (19.23) 30 (22.56) SAH (aneurysm rupture) 10 (38.46) 29 (21.80) SAH (AVM rupture) 0 (0) 0 (0) Cerebral infarction 0 (0) 0 (0) Tumor 2 (7.69) 8 (6.02) Infection 0 (0) 4 (3.01) Primary hydrocephalus 3 (11.54) 19 (14.29) Pre-Craniotomy, n (%) 9 (34.62) 56 (42.11) 0.477 Pre-Decompression, n (%) 8 (30.77) 50 (37.59) 0.508 Pre-EVD, n (%) 16 (61.54) 42 (31.58) 0.004a Pre-Cranioplasty, n (%) 2 (7.69) 23 (17.29) 0.350 LP pressure (mmH2 O) 141.54 ± 60.93 139.42 ± 64.94 0.878 CSF protein (g/L) 0.56 ± 0.46 0.64 ± 0.60 0.509 CSF glucose (mmol/L) 3.87 ± 1.45 3.88 ± 1.35 0.980 CSF nucleated cells (106 /L) 16.31 ± 20.16 11.68 ± 17.15 0.223 WBC (109 /L) 8.37 ± 3.10 7.97 ± 2.82 0.512 Neutrophils (109 /L) 5.55 ± 2.97 5.41 ± 2.63 0.810 Lymphocyte (109 /L) 1.89 ± 0.55 1.75 ± 0.59 0.237 NLR 3.40 ± 2.79 3.48 ± 2.20 0.869 RBC (1012 /L) 4.04 ± 1.54 3.88 ± 0.69 0.407 HGB (g/L) 112.88 ± 15.44 114.71 ± 18.15 0.631 PLT (109 /L) 276.31 ± 68.61 280.92 ± 102.98 0.827 PLR 160.46 ± 69.01 184.02 ± 105.17 0.275 PT(s) 11.64 ± 1.24 11.40±1.26 0.374 INR 1.01 ± 0.11 0.99 ± 0.11 0.382 Fib (g/L) 4.88 ± 7.40 3.67 ± 1.60 0.416 Potassium (mmol/L) 3.85 ± 0.42 3.81 ± 0.43 0.680 Sodium (mmol/L) 136.68 ± 5.19 138.34 ± 5.30 0.144 Calcium (mmol/L) 2.23 ± 0.12 2.22 ± 0.17 0.796 Blood glucose (mmol/L) 5.92 ± 1.45 6.17 ± 2.34 0.591 SBP (mmHg) 137.46 ± 21.35 140.14 ± 24.84 0.609 DBP (mmHg) 86.50 ± 13.22 85.71 ± 14.08 0.791 Hypertension, n (%) 10 (38.46) 49 (36.84) 0.876 Other basic disease, n (%) 3 (11.54) 16 (12.03) 1.000 Smoker, n (%) 7 (26.92) 31 (23.31) 0.693 Prior Blood transfusion, n (%) 6 (23.08) 48 (36.09) 0.200 Operation time (min) 73.46 ± 34.58 74.35 ± 26.86 0.883 Location of VP shunt, n (%) 0.250 Frontal 23 (88.46) 101 (75.94) Occiptal 3 (11.54) 32 (24.06) Other VP Complications, n (%) 1 (3.85) 10 (7.52) 0.801 Brain edema around catheter, n (%) 15 (57.69) 34 (25.56) 0.000a Pre-mRS, n (%) 0.281 Low (0-2) 8 (30.77) 56 (42.11) High (3-5) 18 (69.23) 77 (57.89) Post-mRS, n (%) 0.024 Low (0-2) 9 77 High (3-5) 17 55
Table 2 Univariate analysis of variable relating to delayed intracranial hemorrhage in ventriculoperitoneal shunt patients
Variables DICH group (n = 26) Non-DICH group (n = 133) P value Demographics Age (yr) 51.35 ± 12.08 53.89 ± 15.17 0.420 Male gender, n (%) 17 (65.38) 66 (49.62) 0.145 Primary clinical diagnosis, n (%) Traumatic brain injury 6 (23.07) 43 (17.29) Intracranial hemorrhage 5 (19.23) 30 (22.56) SAH (aneurysm rupture) 10 (38.46) 29 (21.80) SAH (AVM rupture) 0 (0) 0 (0) Cerebral infarction 0 (0) 0 (0) Tumor 2 (7.69) 8 (6.02) Infection 0 (0) 4 (3.01) Primary hydrocephalus 3 (11.54) 19 (14.29) Pre-Craniotomy, n (%) 9 (34.62) 56 (42.11) 0.479 Pre-Decompression, n (%) 8 (30.77) 50 (37.59) 0.510 Pre-EVD, n (%) 16 (61.54) 42 (31.58) 0.005a Pre-Cranioplasty, n (%) 2 (7.69) 23 (17.29) 0.233 LP pressure (mmH2 O) 141.54 ± 60.94 139.42 ± 64.94 0.877 CSF protein (g/L) 0.56 ± 0.46 0.64 ± 0.60 0.509 CSF glucose (mmol/L) 3.87 ± 1.45 3.88 ± 1.35 0.980 CSF nucleated cells (106 /L) 16.31 ± 20.16 11.68 ± 17.15 0.229 WBC (109 /L) 8.37 ± 3.10 7.97 ± 2.82 0.510 Neutrophils (109 /L) 5.55 ± 2.97 5.41 ± 2.63 0.808 Lymphocyte (109 /L) 1.89 ± 0.55 1.75 ± 0.59 0.237 NLR 3.40 ± 2.79 3.48 ± 2.20 0.868 RBC (1012 /L) 4.04 ± 1.54 3.88 ± 0.69 0.415 HGB (g/L) 112.88 ± 15.44 114.71 ± 18.15 0.629 PLT (109 /L) 276.31 ± 68.61 280.92 ± 102.97 0.826 PLR 160.46 ± 69.01 184.02 ± 105.17 0.276 PT(s) 11.64 ± 1.24 11.40 ± 1.26 0.373 INR 1.01 ± 0.11 0.99 ± 0.11 0.381 Fib (g/L) 4.88 ± 7.40 3.67 ± 1.60 0.183 Potassium (mmol/L) 3.85 ± 0.42 3.81 ± 0.43 0.678 Sodium (mmol/L) 136.68 ± 5.19 138.34 ± 5.30 0.145 Calcium (mmol/L) 2.23 ± 0.12 2.2238 ± 0.17 0.795 Blood glucose (mmol/L) 5.92 ± 1.45 6.17 ± 2.34 0.589 SBP (mmHg) 137.46 ± 21.35 140.14 ± 24.84 0.607 DBP (mmHg) 86.50 ± 13.22 85.71 ± 14.08 0.790 Hypertension, n (%) 10 (38.46) 49 (36.84) 0.876 Other basic disease, n (%) 3 (11.54) 16 (12.03) 0.944 Smoker, n (%) 7 (26.92) 31 (23.31) 0.693 Prior Blood transfusion, n (%) 6 (23.08) 48 (36.09) 0.205 Operation time (min) 73.46 ± 34.58 74.35 ± 26.86 0.882 Location of VP shunt, n (%) 0.170 Frontal 23 (88.46) 101 (75.94) Occiptal 3 (11.54) 32 (24.06) Other VP complications, n (%) 1 (3.85) 10 (7.52) 0.508 Brain edema around catheter, n (%) 15 (57.69) 34 (25.56) 0.000a Pre-mRS, n (%) 0.523 0-2 8 (30.77) 56 (42.11) 3-5 18 (69.23) 77 (57.89)
Table 3 Multivariate analysis of variable relating to delayed intracranial hemorrhage in ventriculoperitoneal shunt patients
Variable P value OR 95%CI Age (yr) 0.162 0.975 0.942-1.010 Pre-Craniotomy 0.548 0.723 0.250-2.085 Pre-EVD 0.045 2.814 1.024-7.730 PT(s) 0.224 1.268 0.865-1.859 Location of VP shunt 0.153 2.775 0.685-11.249 Brain edema around catheter 0.000 8.397 3.043-23.171
Table 4 Summary of 26 patients with delayed intracranial hemorrhage after ventriculoperitoneal shunt
No. Age/sex Primary intracranial lesion History of EVD Location of VP shunt DICH type Onsetday Treatment Pre-mRS Post-mRS 1 50/F Aneurysm Y Frontal IVH 2 Conservative 1 1 2 67/M ICH Y Frontal ICH around catheter 3 Conservative 3 1 3 64/M Aneurysm Y Frontal IVH 1 Conservative 1 1 4 37/F Tumor N Occipital ICH around catheter 11 Conservative 5 4 5 56/M TBI Y Frontal ICH around catheter 3 Conservative 5 5 6 23/M TBI N Frontal ICH around catheter 4 Conservative 5 5 7 63/F Aneurysm N Frontal ICH around catheter 7 Surgery 4 5 8 54/M Aneurysm Y Frontal ICH around catheter 3 Conservative 5 5 9 61/M Aneurysm Y Occipital ICH around catheter 5 Conservative 2 1 10 47/M ICH Y Frontal ICH around catheter 7 Conservative 5 5 11 58/M Aneurysm Y Frontal IVH 7 Conservative 2 2 12 51/F Aneurysm N Frontal ICH around catheter 3 Conservative 1 1 13 58/M Tumor N Frontal ICH around catheter 2 Conservative 5 5 14 58/F Primary hydrocephalus N Frontal Subdural hematoma 7 Conservative 5 5 15 47/M Primary hydrocephalus N Frontal ICH around catheter 5 Conservative 4 4 16 53/M TBI Y Frontal IVH 2 Conservative 5 3 17 42/M Aneurysm Y Frontal ICH around catheter 9 Conservative 5 5 18 32/M Aneurysm Y Occipital IVH 1 Conservative 2 2 19 45/M TBI Y Frontal ICH around catheter 1 Conservative 5 5 20 62/M ICH Y Frontal Subdural hematoma 2 Conservative 5 5 21 47/F TBI Y Frontal ICH around catheter 2 Conservative 4 4 22 56/M ICH N Frontal IVH 7 Conservative 5 4 23 47/M ICH N Frontal Subdural hematoma 4 Surgery 5 5 24 26/F Primary hydrocephalus Y Frontal IVH 8 Conservative 2 2 25 72/F Aneurysm Y Frontal IVH 1 Conservative 1 1 26 59/F TBI N Frontal IVH 1 Conservative 5 5
Table 5 Summary of the previous studies of delayed intracranial hemorrhage after ventriculoperitoneal shunt
Ref. Year DICH Non-DICH Number of variables Proposed risk factors Hudson et al [18 ] 2018 8 72 10 DAPT (P = 0.0001, OR = 31.23, 95%CI: 2.98-327.32) Guo et al [15 ] 2017 20 512 8 Advanced age (P = 0.027, OR = 1.048, 95%CI: 1.005-1.092), craniotomy history (P = 0.025, OR = 3.874, 95%CI: 1.183-12.693), brain edema around the catheter (P < 0.001, OR = 9.056, 95%CI: 3.194-25.675) Gong et al [16 ] 2017 12 742 9 Age ≥ 60 yr (P = 0.0008), prior craniotomy operation (P = 0.0001) and manipulation of the valve system (P = 0.0017) Qian et al [14 ] 2017 11 140 18 Postoperative LMWH therapy (P = 0.026, relative ratio = 4.8, 95%CI: 1.4-17.1) Jang et al [17 ] 2018 34 104 9 Old age (P = 0.037) and delayed PTT (P = 0.032) Li et al [6 ] 2021 29 101 21 Elevated NLRR (P < 0.001, OR = 2.792, 95%CI: 1.747-4.460); history of craniotomy (P = 0.010, OR = 3.394, 95%CI: 1.060-10.869)